GREAT WEST LIFE ASSURANCE CO /CAN/ - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 3 filers reported holding REATA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$222
+91.4%
2,167
+69.4%
0.00%
Q1 2023$116
+103.5%
1,279
-14.9%
0.00%
Q4 2022$57
-99.8%
1,5030.0%0.00%
Q3 2022$38,000
-17.4%
1,5030.0%0.00%
Q2 2022$46,000
-11.5%
1,5030.0%0.00%
Q1 2022$52,000
+30.0%
1,5030.0%0.00%
Q4 2021$40,000
-73.7%
1,5030.0%0.00%
Q3 2021$152,000
-28.3%
1,5030.0%0.00%
Q2 2021$212,000
+43.2%
1,5030.0%0.00%
Q1 2021$148,000
-24.1%
1,503
-4.9%
0.00%
Q4 2020$195,000
+26.6%
1,5810.0%0.00%
Q3 2020$154,000
-36.9%
1,5810.0%0.00%
-100.0%
Q2 2020$244,000
+22.6%
1,581
+15.8%
0.00%0.0%
Q1 2020$199,000
-28.2%
1,3650.0%0.00%0.0%
Q4 2019$277,000
+16.9%
1,365
-45.6%
0.00%0.0%
Q2 2019$237,000
-5.6%
2,510
-15.0%
0.00%0.0%
Q1 2019$251,000
+128.2%
2,952
+45.3%
0.00%
Q4 2018$110,000
+48.6%
2,031
+125.7%
0.00%
Q3 2018$74,000
+138.7%
9000.0%0.00%
Q2 2018$31,000
+72.2%
9000.0%0.00%
Q1 2018$18,000
-28.0%
9000.0%0.00%
Q4 2017$25,000
-10.7%
9000.0%0.00%
Q3 2017$28,0000.0%9000.0%0.00%
Q2 2017$28,0009000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders